Introduction
The regulation of many human genes is controlled by multiple discrete enhancer sequences with different tissue specificities (e.g. references [1] [2] [3] [4] [5] [6] ). Such enhancers activate gene expression independent of their orientation [7] and are commonly scattered across large noncoding intervals [8, 9] , in some extreme cases functioning N1 Mb from their gene promoter target [10, 11] . While progress towards genome-wide annotation of developmental enhancers has been made by coupling comparative genomic and chromatin immunoprecipitation-sequencing approaches to experimental studies in mice and fish [12] [13] [14] [15] , the functional and evolutionary significance of their dispersed arrangement remains unclear. Structural modularity of enhancer architecture may facilitate evolutionary fine tuning of distinct aspects of expression patterns [16, 17] , but observations in invertebrate models [18, 19] have also raised the possibility that intergenic translocation of preformed enhancer modules may have contributed to the evolution of complex gene expression patterns in vertebrates. However, an open question remains whether this proposed mechanism of regulatory evolution is feasible since it requires that enhancers accurately retain their individual activities when placed into a new genomic context.
Results

Heterologous pairs of enhancers have additive regulatory properties
To explore the prevalence of possible positive or negative interactions among human developmental enhancers, we recombined enhancer modules from different, functionally unrelated genes and studied their regulatory in vivo properties during embryonic development in transgenic mice. We selected for this purpose six in vivo validated enhancers [12, 13] (E1-E6, Fig. 1a ; Suppl. Table 1 ). When individually coupled to a minimal heat shock protein 68 promoter linked to a LacZ reporter gene ( Fig. 1b; [13, 20] ), each of these elements drove reproducible tissue-specific expression in transgenic mouse embryos. Representative patterns observed with these single enhancers are shown in Fig. 1c . Of note, the enhancers were selected for analysis based on their expression patterns which are easily distinguished at the resolution of whole-mount staining, yet also include features that are located in close spatial proximity. In particular, activity patterns comprise different subregions of the developing forebrain (E2 and E6), the midbrain (E5 and E6), the hindbrain (E5 and E6), and three different subregions of the developing limb (E1, E3, and E4). A detailed overview of the strong reproducibility of these features in independent transgenic embryos, as well as additional reproducible features that were observed for the individual patterns, is provided in Suppl. Table 2 . All elements are located on different human chromosomes and thereby are expected to regulate independent gene(s), with the exception of E1 and E2 which are within introns of different genes on chromosome 1 but are located more than 5 Mb apart from each other. All elements are located at least 30 kb away from the closest known promoter, with 4 elements found within genes (E1, E2, E3 and E6) and the remaining 2 elements found between genes (E4 and E5).
These enhancers are experimentally defined by their ability to drive reporter gene expression in transgenic mouse embryos, but (as for most human developmental enhancers) it is unknown whether additional cis-regulatory cues such as general or tissue-specific repressor/silencer activities are also embedded in these elements that might affect the activity of other regulatory elements in their vicinity. To determine the combinatorial properties of these human enhancers, we generated five constructs containing pair-wise tandem fusions of the heterologous enhancers described above (Fig. 1b) . For each construct, we obtained multiple transgenic embryos at e11.5 (representing 8 to 15 independent transgenic integration events, see Suppl. Table 2 ). In each of the cases studied we observed reproducible patterns that were a direct superimposition of the two individual patterns ( Fig. 1d-h ). For instance, as one representative example, a construct containing E2 (forebrain) coupled to E5 (medial-dorsal and lateral cell populations of the midbrain and ventral hindbrain) targets reporter gene expression to the same respective subregions of the fore-, mid-and hindbrain as observed for E2 and E5 alone (Fig. 1c, e) . Using the presence of reproducible staining in individual anatomical structures as a qualitative measure, we observed no disruption of enhancer activities in the tandem fusion constructs in comparison to each enhancer element alone (Suppl. Table 2 ). Conversely, the concatenation of heterologous enhancers did not result in any reproducible staining in additional anatomical structures or domains outside of those observed for the individual enhancer constructs. These data indicate that in all instances tested, the two enhancers retained their specificity independent of each other despite the artificial coupling of enhancer modules that regulate different genes.
Complex but predictable regulatory output from a heterologous multi-enhancer array
To test whether more complex combinations of enhancer modules would result in positive or negative interactions, we concatenated four different enhancers from unrelated genes and tested the activity of this compound construct at embryonic day 11.5. Similar to the additive results observed in the combination of two discrete enhancers, independent transgenic embryos for the compound 4-mer construct had highly reproducible patterns that included all the major features of the individual patterns, while not introducing additional reproducibly stained structures (Fig. 1i , Suppl. Table 2 ). Thus, even when multiple distant-acting enhancers were combined in close proximity in a single construct, the individual enhancer units retained their distinct spatial specificities at this time-point.
Both spatial and temporal regulatory specificity are preserved
In addition to spatial properties, we also examined temporal aspects of expression driven by concatenated enhancers. We selected for this purpose construct E3 + E4, containing a pair of enhancers that drove expression in the developing limb (Fig. 1f) , where morphological changes enable precise developmental stage matching of independently generated transgenic embryos. When tested individually at stages ranging from e10.5 to e12.5, enhancer E3 alone targets expression to the apical ectodermal ridge (AER) and the surface ectoderm of the limb bud (Fig. 2a-d) . In contrast, E4 alone does not drive limb staining at e10.5, but targets expression to a sharply restricted central cell population in the limb at e11.5 that continues Table 2 for reproducibility across independent transgenic animals. throughout e12.5 (Fig. 2e-h) . In order to compare the developmental progression of expression driven by constructs E3, E4, and E3 + E4, we collected multiple transgenic embryos at e10.5, e11.5 and e12.5 for each construct. We found that the compound construct E3 + E4 drove AER expression at all time-points examined, whereas the medial expression domain was first observed at e11.5 as with E4 alone, indicating that the developmental onset of expression driven by E4 is not affected by the presence of E3 in its immediate proximity. Taken together, these results indicate that the functional independence of human developmental enhancers and the absence of obvious regulatory interference among them could allow the generation of complex spatiotemporal expression patterns through modular intergenic recombination of enhancers.
Discussion
The high degree of regulatory autonomy observed in this study suggests that functional independence and spatiotemporal additivity are common features of human distant-acting enhancer modules. Only a limited number of permutations of a small subset of human enhancers were tested in the present study, therefore it remains to be determined whether these properties are a universal feature applying to all developmental enhancers. Moreover, the LacZ-based approach used in this study provides direct evidence for qualitative additivity of patterns, yet we cannot exclude the possibility that subtle quantitative differences in enhancer activities between single and compound constructs were not detectable. These potential limitations notwithstanding, our results indicate that emerging collections of human and other vertebrate enhancers [12] [13] [14] [15] provide a toolbox enabling the design of regulatory composites driving customized, complex in vivo expression patterns in a predictable manner due to the additive nature of the individual components.
These observations also have potential evolutionary implications, as it has been proposed that duplication of regulatory elements into new genomic locations may have contributed to the emergence of complex gene expression patterns [17, 21, 22] . Bona fide examples of intergenic enhancer shuffling in the human genome remain to be identified, but recent comparative genomic evidence suggests that exaptation of transposable genome elements occurred on a pervasive scale [23] . While some of these mobile elements gave rise to functional enhancers [24, 25] , it remains uncertain whether such transposon-derived elements typically arose de novo or if partially preformed cis-regulatory functions were already embedded at the time of their translocation.
The remarkable modular additivity of spatial and temporal enhancer activities indicates that functional distant-acting enhancers, if translocated into new genomic environments, have the potential to transfer aspects of expression patterns between genes without disrupting the function of pre-existing enhancers. We expect that the combinatorial properties of human enhancers demonstrated through our experiments will provide confidence and a conceptual basis for constructing increasingly complex arrays of enhancers by homologous recombination in mice, which is expected to provide further insights into enhancer shuffling as a potential mechanism of vertebrate genome evolution.
Materials and methods
Enhancer reporter constructs
All enhancer sequences were PCR amplified from human genomic DNA (Clontech) using the primers listed in Suppl. Table  1 . PCR fragments were cloned into the pENTR plasmid (Invitrogen), transferred into an Hsp68-LacZ reporter vector containing a Gateway cassette using LR recombination (Invitrogen; [13, 20] ) and sequence validated.
Compound enhancers
To generate compound enhancers, inserts from individual constructs were subcloned by standard molecular cloning techniques. Sequence and orientation of enhancers in the final constructs are indicated in Suppl. Table 1 . Residual multiple cloning site fragments of up to 48 bp residing between enhancers are also listed in Suppl. Table 1 .
Transgenic mice
Transgenic mouse embryos were generated by pronuclear injection in accordance with protocols reviewed and approved by the Lawrence Berkeley National Laboratory Animal Welfare and Research Committee. Zygotes at 0.5 dpc for pronuclear injection were collected from FVB strain donor females (Charles River) and, after injection, transferred into pseudopregnant CD-1 strain recipient females (Charles River). Embryos were collected and stained for LacZ activity as previously described [8] .
Assessment of reporter gene expression
Only anatomical structures in which reporter gene expression was present in at least three embryos resulting from independent transgene integration events were considered reproducible. Reproducibilities for all patterns observed with individual and compound enhancers are listed in Suppl. Table 2 .
